Deutsche Bank Aktiengesellschaft »

Crispr Therapeutics shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.2M 65k 64.81
2025-06-30 $2.8M 57k 48.64
2025-03-31 $281k 8.2k 34.03
2024-12-31 $320k 8.1k 39.36
2024-09-30 $232k 4.9k 46.98
2024-06-30 $260k 4.8k 54.01
2024-03-31 $354k 5.2k 68.16
2023-12-31 $317k 5.1k 62.60
2023-09-30 $210k 4.6k 45.39
2023-06-30 $260k 4.6k 56.14
2023-03-31 $380k 8.4k 45.23
2022-12-31 $190k 4.7k 40.65
2022-09-30 $49k 743 65.95
2022-06-30 $7.5M 124k 60.77
2022-03-31 $7.8M 124k 62.77
2021-12-31 $197k 2.6k 75.62
2021-09-30 $345k 3.0k 116.67
2021-06-30 $693k 4.2k 164.38
2021-03-31 $9.6M 79k 121.62
2020-12-31 $25M 161k 156.46
2020-09-30 $4.5M 54k 84.07
2020-06-30 $4.3M 59k 72.58
2020-03-31 $136k 3.1k 44.35
2019-12-31 $8.2M 134k 60.90
2019-09-30 $1.5M 37k 40.98
2019-06-30 $22k 476 45.21
2019-03-31 $16k 467 33.71
2018-12-31 $150k 5.3k 28.38
2018-09-30 $0 8 0.00
2018-06-30 $0 155k 0.00
2018-03-31 $861k 19k 45.69
2017-12-31 $1.4M 58k 23.46
2017-09-30 $506k 28k 17.84
2017-06-30 $8.0k 500 16.00
2017-03-31 $150k 6.9k 21.74